Linked from

The 15 pages that link to Amphetamine, each with the reason it gives.

• CatecholamineRelated: It raises catecholamine signaling by altering release and transporter activity.

• CocaineCompared with: Unlike cocaine’s primary reuptake blockade, amphetamine can promote neurotransmitter release.

• Synaptic vesicleRelated: Amphetamine can disrupt vesicular monoamine storage and promote transmitter release.

• MethylphenidateCompared with: Amphetamines treat ADHD too, but promote neurotransmitter release more directly than methylphenidate.

• MethamphetamineCompared with: It shares stimulant mechanisms with methamphetamine but differs in potency, pharmacology, and typical patterns of use.

• StimulantBroader topic: It is used medically and also has substantial misuse and dependence risks.

• EphedrineCompared with: Both can stimulate sympathetic activity, but amphetamine has stronger central stimulant effects and different clinical uses.

• ModafinilCompared with: Its stronger stimulant profile helps distinguish modafinil's effects and misuse risks.

• TyramineCompared with: Amphetamine shares indirect monoamine-releasing actions but is a drug with distinct potency and central effects.

• Monoamine transporterRelated: It can make transporters release monoamines instead of merely blocking uptake.

• PhenethylamineBroader topic: Adding an α-methyl group to the scaffold gives amphetamine its defining structure.

• AtomoxetineCompared with: Unlike amphetamine, atomoxetine does not promote monoamine release and is not a controlled stimulant.

• SelegilineRelated: Selegiline is metabolized partly into amphetamine-like compounds that may contribute to adverse effects.

• DextroamphetamineNarrower topic: Dextroamphetamine is one stereoisomer within the broader amphetamine family.

• CathinoneRelated: Cathinone shares amphetamine’s core structure and stimulant profile.